Testing Effectiveness of Losartan in Patients With EoE With or Without a CTD

PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

October 10, 2013

Primary Completion Date

January 13, 2015

Study Completion Date

February 13, 2015

Conditions
Eosinophilic EsophagitisConnective Tissue Disorders
Interventions
DRUG

Losartan Potassium

The dose of study drug is dependent on body weight and tolerance but did not exceed 100 mg.

Trial Locations (1)

45040

Kara Kliewer, Mason

All Listed Sponsors
lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT01808196 - Testing Effectiveness of Losartan in Patients With EoE With or Without a CTD | Biotech Hunter | Biotech Hunter